To further characterize how PD-L1/miR-27a-3p-enriched EVs modulate CD4+ T-cell responses, we performed single-cell RNA sequencing (scRNA-seq) on splenic CD4+ T cells isolated from humanized mice models of colitis treated with either PBS or dual-targeting EVs (Fig. 8a). The gene discussed is CD4; the disease is colitis.